These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 16490518

  • 21. [Endophthalmitis following intravitreal triamcinolone acetonid injection--a case report].
    Jamrozy-Witkowska A, Grabska-Liberek I, Kowalska K, Oficjalska-Młyńczak J.
    Klin Oczna; 2010; 112(1-3):57-60. PubMed ID: 20572506
    [Abstract] [Full Text] [Related]

  • 22. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
    Moshfeghi AA, Scott IU, Flynn HW, Puliafito CA.
    Am J Ophthalmol; 2004 Sep; 138(3):489-92. PubMed ID: 15364241
    [Abstract] [Full Text] [Related]

  • 23. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
    Al-Haddad CE, Jurdi FA, Bashshur ZF.
    Am J Ophthalmol; 2004 Jun; 137(6):1151-3. PubMed ID: 15183815
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.
    Audren F, Lecleire-Collet A, Erginay A, Haouchine B, Benosman R, Bergmann JF, Gaudric A, Massin P.
    Am J Ophthalmol; 2006 Nov; 142(5):794-99. PubMed ID: 16978576
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years.
    Islam MS, Vernon SA, Negi A.
    Eye (Lond); 2007 Mar; 21(3):321-3. PubMed ID: 16543927
    [Abstract] [Full Text] [Related]

  • 26. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H, Habot-Wilner Z, Alhalel A, Moroz I, Glovinsky J, Moisseiev J.
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [Abstract] [Full Text] [Related]

  • 27. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ, Zaheer I, Karia N.
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [Abstract] [Full Text] [Related]

  • 28. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB, Verma V, Realini T, Prenner JL, Feuer WJ, Fechtner RD.
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [Abstract] [Full Text] [Related]

  • 32. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW, Park SC, Cho HY, Kang JH.
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [Abstract] [Full Text] [Related]

  • 33. Pathergy-like reaction following intravitreal triamcinolone acetonide injection in a patient with Behçet disease.
    Yalçindağ FN, Batioğlu F.
    Ocul Immunol Inflamm; 2008 Dec; 16(4):181-3. PubMed ID: 18716954
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T, Dhawan M, Garg S, Nair S, Mandal S.
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T, Uemura A, Kita H, Sakamoto T.
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [Abstract] [Full Text] [Related]

  • 37. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
    Kim JE, Pollack JS, Miller DG, Mittra RA, Spaide RF, Isis Study Group.
    Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].
    Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG.
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):638-42. PubMed ID: 16118744
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.